Multimodal sensing and machine learning to detect mental and social states

Novel Multimodal Neural, Physiological, and Behavioral Sensing and Machine Learning for Mental States

Not applicable Interventional University of Southern California · NCT07110688

This project will test wearable skin sensors, a conversational virtual human, audiovisual emotion recognition, and machine-learning models to detect mental states in healthy adults and in adults with drug‑resistant epilepsy who already have intracranial EEG implants.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment90 (estimated)
Ages18 Years and up
SexAll
SponsorUniversity of Southern California Academic / other
Locations2 sites (Downey, California and 1 other locations)
Trial IDNCT07110688 on ClinicalTrials.gov

What this trial studies

The program develops integrated hardware and software: a skin‑like wearable that measures physiological and biochemical signals, a conversational virtual human platform to evoke natural social responses, audiovisual affect recognition software, synchronization tools, and machine‑learning methods to model the combined data. Researchers will record responses during virtual social interactions and controlled challenges such as the cold pressor test in healthy volunteers and in patients who already have clinically implanted intracranial EEG (iEEG) electrodes. The iEEG recordings are from electrodes placed for clinical seizure localization and are unrelated to clinical care changes. The goal is to demonstrate that multimodal signals can be synchronized and modeled to reveal moment‑to‑moment mental and social states.

Who should consider this trial

Good fit: Ideal candidates are adults (≥18) who can give informed consent and either are healthy volunteers or have drug‑resistant epilepsy with already‑implanted intracranial EEG electrodes and can follow study instructions.

Not a fit: People under 18, patients without implanted iEEG, or individuals unable to consent or cooperate are unlikely to be eligible or to receive direct benefit from this protocol.

Why it matters

Potential benefit: If successful, these tools could enable more precise, real‑time detection of emotional and cognitive states and support development of wearable monitoring and brain‑based diagnostics.

How similar studies have performed: Components like affect recognition, wearable physiological sensing, and iEEG state decoding have shown promise in prior work, but combining these multimodal measures with virtual conversational platforms and biochemical skin sensors is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
For the healthy population, all subjects over the age of 18 who are able and willing to give informed consent will be eligible.

For the epilepsy population, inclusion criteria are:

* Patients who suffer from drug-resistant epilepsy and already have intracranial EEG (iEEG) electrodes implanted based on clinical criteria for their standard seizure localization (unrelated to our study) will be eligible. Most patients are healthy adults outside of their epilepsy.
* Subjects \>= 18 are only included in this study.
* All patients with the above conditions and with already-implanted electrodes who are willing to participate and able to cooperate and follow research instructions will be recruited.

Where this trial is running

Downey, California and 1 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions No ConditionStudy Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEGneurotechnologyneuropsychiatric disordersbrain-machine interface
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.